BIOMAT Database Logo BIOMAT Database Logo

The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients. 1984

M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz

beta-adrenoceptor blocking agents are widely used as treatment of essential hypertension. We studied the action of a new non cardioselective beta-adrenoceptor blocker, mepindolol, comparing its effects on blood pressure, blood lipids and platelet aggregation with those of a cardioselective beta-adrenoceptor blocker, atenolol. Blood pressure fell significantly in the patients treated with both drugs. Triglycerides rose non-significantly only in volunteers treated with mepindolol. We did not find any significant changes in cholesterol, free fatty acids, lipoproteins and platelet aggregation.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
The effect of exercise on platelet beta-adrenoceptor function and platelet aggregation in healthy human volunteers.
April 1988, Clinical physiology (Oxford, England),
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol.
December 1983, British journal of clinical pharmacology,
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
June 1997, British journal of clinical pharmacology,
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers.
January 2006, The American journal of Chinese medicine,
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
January 1989, British journal of clinical pharmacology,
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
[Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
December 1989, Arquivos brasileiros de cardiologia,
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
Effect of beta-blockers on psychomotor performance in normal volunteers.
January 1985, European journal of clinical pharmacology,
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
Platelet aggregation and beta-blockers.
January 1982, Lancet (London, England),
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
beta-adrenoceptor blockers reduce blood pressure in normal subjects.
January 1983, British journal of clinical pharmacology,
M Luque Otero, and C Fernandez Pinilla, and A Escriba Polo, and M Rodriguez Vazquez, and N Martell Claros, and A Fernandez-Cruz
[Evaluation of platelet aggregation in essential hypertensive patients].
October 1977, Haematologica,
Copied contents to your clipboard!